LONDON (Alliance News) - Biotechnology company Oxford Biodynamics PLC said Friday Chair David Williams and Non-Executive Director Alison Kibble will stand down later in 2019.
Williams - chair since 2016 - will leave at the annual general meeting in March. He will continue in his role until an appointment has been made, and will work closely to ensure a smooth transition.
"It has been a pleasure to work with the board and management team to serve shareholders as Oxford BioDynamics has transitioned to become a listed business," Williams said.
"The company has grown significantly since its IPO in December 2016, increasing its international footprint, its portfolio of intellectual property, and the range of global pharma and biopharma companies on its roster," Williams added. "Now is the right time for me to step down, as the company enters the next phase of growth. I am confident that the company will continue to go from strength to strength."
Oxford Biodynamics Chief Executive Officer Christian Hoyer Millar thanked Williams for his invaluable "support and significant contribution" to the firm.
Kibble - a non-exec since 2007 - also intends to stand down sometime during the course of 2019. She will also remain on the board until her replacement is chosen.
Hoyer Millar also thanked Kibble for "her long service and valuable contributions over a period which has been transformational for the company. Alison has made an invaluable contribution to the company from the very first spin out from the University of Oxford."
Shares in Oxford Biodynamics were 1.4% lower at 201.20 pence on Friday.
Oxford Biodyn (OBD)